XML 92 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Option Activities of Long-Term Incentive and Option Plans The following information relates to our long-term incentive plans:

 

 

December 31, 2019

 

 

 

2016 Plan

 

 

2008 Plan

 

Maximum number of securities for issuance

 

 

2,750,000

 

 

 

 

 

Number of awards available to be granted (1)

 

 

1,285,922

 

 

 

 

 

Number of unvested restricted stock/performance-based

   restricted stock/restricted stock units outstanding

 

 

925,851

 

 

 

 

Number of options outstanding

 

 

 

 

 

124,000

 

Number of options exercisable

 

 

 

 

 

111,750

 

.

(1)

Includes 2008 Plan shares canceled, forfeited, expired unexercised, which became available for reissuance under the 2016 Plan after the effective date of the 2016 Plan.

 

 

 

2019

 

 

 

Shares

 

 

Weighted-Average

Exercise Price

 

Outstanding at beginning of year

 

 

124,000

 

 

$

33.86

 

Granted

 

 

 

 

$

 

Exercised

 

 

 

 

$

 

Forfeited or expired

 

 

 

 

$

 

Outstanding at end of year

 

 

124,000

 

 

$

33.86

 

Exercisable at end of year

 

 

111,750

 

 

$

33.91

 

 

 

 

2019

 

 

2018

 

 

2017

 

Stock-based compensation expense - Cost of sales

 

$

122,000

 

 

$

141,000

 

 

$

317,000

 

Stock-based compensation expense - SG&A

 

$

50,000

 

 

$

71,000

 

 

$

108,000

 

Income tax benefit

 

$

(42,000

)

 

$

(54,000

)

 

$

(164,000

)

Total intrinsic value of options exercised during the year

 

$

 

 

$

 

 

$

 

Total fair value of options vested during the year

 

$

169,000

 

 

$

169,000

 

 

$

451,000

 

Total intrinsic value of options outstanding at end of year

 

$

 

 

$

 

 

$

16,000

 

Total intrinsic value of options exercisable at end of year

 

$

 

 

$

 

 

$

16,000

 

Total weighted-average remaining vesting period in years

 

0.49

 

 

 

1.05

 

 

 

1.53

 

Total weighted-average remaining contractual life period in years (options outstanding)

 

3.61

 

 

 

4.61

 

 

 

5.10

 

Total weighted-average remaining contractual life period in years (options exercisable)

 

3.47

 

 

 

4.31

 

 

 

4.44

 

 

Summary of Restricted Stock Activity

A summary of restricted stock activity during 2019 is presented below:

 

 

 

Restricted Stock

 

 

Performance-Based

Restricted Stock

 

 

Restricted Stock Units

 

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Unvested restricted stock outstanding at

   beginning of year

 

 

739,465

 

 

$

7.79

 

 

 

 

 

$

 

 

 

68,334

 

 

$

8.23

 

Granted

 

 

285,956

 

 

$

4.28

 

 

 

221,439

 

 

$

7.26

 

 

 

31,833

 

 

$

5.89

 

Vested

 

 

(407,349

)

 

$

8.27

 

 

 

 

 

$

 

 

 

(13,827

)

 

$

13.56

 

Cancelled or forfeited

 

 

 

 

$

 

 

 

 

 

$

 

 

 

 

 

$

 

Unvested restricted stock outstanding at end

   of year

 

 

618,072

 

 

$

5.42

 

 

 

221,439

 

 

$

7.26

 

 

 

86,340

 

 

$

6.51

 

 

 

 

Restricted Stock

 

 

 

2019

 

 

2018

 

 

2017

 

Shares of restricted stock granted

 

 

285,956

 

 

 

369,350

 

 

 

469,465

 

Total fair value of restricted stock granted

 

$

1,223,000

 

 

$

2,019,000

 

 

$

4,277,000

 

Weighted-average fair value per restricted stock granted during year

 

$

4.28

 

 

$

5.47

 

 

$

9.11

 

Stock-based compensation expense - Cost of sales

 

$

255,000

 

 

$

385,000

 

 

$

312,000

 

Stock-based compensation expense - SG&A (1)

 

$

1,263,000

 

 

$

7,574,000

 

 

$

3,987,000

 

Income tax benefit

 

$

(374,000

)

 

$

(398,000

)

 

$

(1,659,000

)

Total weighted-average remaining vesting period in years

 

2.18

 

 

 

1.78

 

 

 

1.95

 

Total fair value of restricted stock vested during the year

 

$

3,371,000

 

 

$

7,355,000

 

 

$

3,124,000

 

 

 

 

 

Performance-Based

Restricted Stock

 

 

 

2019 (2)

 

Shares of PBRS granted

 

 

221,439

 

Total fair value of PBRS granted

 

$

1,608,000

 

Weighted-average fair value per PBRS granted during year

 

$

7.26

 

Stock-based compensation expense - Cost of sales

 

$

53,000

 

Stock-based compensation expense - SG&A

 

$

290,000

 

Income tax benefit

 

$

(84,000

)

Total weighted-average remaining vesting period in years

 

 

1.85

 

Total fair value of PBRS vested during the year

 

$

-

 

 

 

 

 

Restricted Stock Units

 

 

 

2019

 

 

2018

 

 

2017

 

Shares of RSU granted

 

 

31,833

 

 

 

35,511

 

 

 

37,992

 

Total fair value of RSU granted

 

$

187,000

 

 

$

187,000

 

 

$

375,000

 

Weighted-average fair value per RSU granted during year

 

$

5.89

 

 

$

5.28

 

 

$

9.87

 

Stock-based compensation expense - SG&A

 

$

187,000

 

 

$

187,000

 

 

$

375,000

 

Income tax benefit

 

$

(46,000

)

 

$

(34,000

)

 

$

(115,000

)

Total weighted-average remaining vesting period in years

 

 

1.57

 

 

 

1.75

 

 

 

3.05

 

Total fair value of RSU vested during the year

 

$

187,000

 

 

$

125,000

 

 

$

250,000

 

 

(1)

As it relates to 2018, see Note 14-Related Party Transactions.

(2)

The PBRS restricted stock grants are tied to our free cash flow, fixed costs per ton of ammonia measured annually over a three-year period and modified based on our ranking relative to total stockholder return (share price appreciation plus dividends reinvested) (“TSR”) versus the companies in our 2019 peer group (“Peer Group”) over a three-year measurement period. The actual number of shares that will vest at the end of the third year will be based on our performance against the metrics set in the award. The threshold performance for free cash flow is 70% and for fixed costs per ton of ammonia is 50% of the targeted improvement with a maximum for each of 120% of target. The TSR modifier will adjust the overall actual performance up or down by as much as 25% based on the our TSR versus the Peer Group average TSR. We estimate the fair value of each PBRS on the date of grant using a Monte Carlo simulation.